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• A retrospective cohort study was run, in which 100 patients with hip fracture randomly selected from an Orthopedics Department were enrolled.
• FRAX tool (without BMD) was performed and patients were questioned about previous or current treatment with antiosteoporotic drugs. From the 100 patients enrolled, 31 couldn't cooperate (because of dementia or other medical intercurrences).
• In this cohort, established threshold for high risk for hip fracture FRAX algorithm missed 21.7% of the patients who actually had a hip fracture.
• Only 14.8% of the patients with high risk for hip fracture were being treated with antiosteoporotic drugs osteoporosis is underdiagnosed and undertreated
• The use of FRAX in clinical practiceespecially in primary healthcarecould improve the intervention on these patients.
• Limitations: small cohort; retrospective study
